Sep 07, 2010 01:00AM

Treatment Of Pain To Feature At PAC10, Australia

The management of persistent pain requires a different approach to that of acute pain. Whereas the initial problem can be addressed with acute pain, persistent pain requires restoration of physical, psychological and social function with minimisation of distress, decreasing the pain to a tolerable level rather than a cure and addressing the whole person in the rehabilitative process...

Sep 06, 2010 09:00AM

Ask Questions, Save Lives; Risk Assessment Of Children's Respiratory Systems Identifies Potential Anesthetic Complications

It is fairly easy to avoid surgical complications in children related to anesthesia administration by asking a few simple questions before arriving at the operating table...

Sep 06, 2010 05:00AM

Relaxed Attitude Towards Medicines Leading To Greater Health Problems, Australia

Australians' blasé attitude towards medicines is leading to further health problems for many people and is placing avoidable pressure on our health system...

Sep 06, 2010 03:00AM

Codeine-Ibuprofen Misuse Results In Serious Morbidity, Australia

Although codeine-ibuprofen can be considered a relatively weak opioid analgesic, it is nevertheless addictive and more research is needed to develop health care responses to its misuse, according to an article in the Medical Journal of Australia...

Sep 06, 2010 12:00AM

Molecules Involved In Touch And Other Mechanically Activated Systems Identified

Scripps Research Institute scientists have identified two proteins with potential to be important targets for research into a wide range of health problems, including pain, deafness, and cardiac and kidney dysfunction. The study was published in Science Express, the advanced, online edition of the journal Science...

Sep 05, 2010 12:00AM

BioDelivery Sciences Announces Positive Meeting With FDA On A Streamlined ONSOLIS REMS With Broadened Distribution

BioDelivery Sciences International, Inc. (NASDAQ:BDSI) announced a positive meeting with the U.S. Food and Drug Administration (FDA), Meda and BDSI that occurred on Wednesday, July 21, 2010 to discuss significant modifications to the existing Risk Evaluation and Mitigation Strategy (REMS) program for ONSOLIS (fentanyl buccal soluble film)...

Sep 04, 2010 02:00AM

Colorado Society Of Anesthesiologists Disagrees With NPATCH's Support To Allow Nurses To Administer Anesthesia Without The Supervision Of A Physician

"The Colorado Society of Anesthesiologists (CSA) strongly disagrees with NPATCH's support for allowing nurses to administer anesthesia without physician supervision. Regrettably, their action was not unexpected. It is disturbing that NPATCH and others would support policies whereby a patient's life-and-death medical decisions would be made by nurses, not doctors...

Sep 03, 2010 02:00AM

Transdel Pharmaceuticals Presents Phase 3 Study Data On Ketotransdel® At World Pain Congress In Montreal, Canada

Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced the final data set from its Phase 3 study of Ketotransdel® (TDLP-110) at the 13th World Congress on Pain in Montreal, Canada...

Sep 03, 2010 02:00AM

Allergan Resolves United States Government Investigation Of Past Sales And Marketing Practices Relating To Certain Therapeutic Uses Of BOTOX(R)

Allergan, Inc. (NYSE: AGN) announced that it has reached a resolution with the United States Department of Justice (DOJ) regarding the previously reported Government investigation into Allergan's past U.S. sales and marketing practices relating to certain therapeutic uses of BOTOX® (onabotulinumtoxinA)...

Sep 03, 2010 02:00AM

Afferent Pharmaceuticals Presents Data Supporting Use Of P2X3 Antagonists In Reducing Bone Cancer Pain

Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecules that target P2X3 receptors, announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist significantly prevented and reversed bone cancer pain behavior in comparison to vehicle controls...

Sep 02, 2010 10:00AM

The Face Of An Infant's Suffering; Can It Be Sugarcoated?

When your newborn infant is crying with uncomfortable teething or otherwise obviously suffering, feeding sugar to the little one has been a home remedy for years based on not only perceived behavior, but also physiological reactions. However, a new article by Dr...

Sep 02, 2010 02:00AM

QRxPharma Announces Interim Analysis Of Final Pivotal Phase 3 Study For MoxDuo®IR

QRxPharma (ASX: QRX and OTCQX: QRXPY) announced a successful interim analysis of its final MoxDuo IR pivotal Phase 3 study required for New Drug Application (NDA) submission. The analysis indicated the planned sample size of 140 patients has greater than 90% power to detect differences of analgesic effect, indicating there is no need to enrol additional patients...

Sep 02, 2010 02:00AM

Floridians Prepare To Take Back The State

September's National Pain Awareness Month has never been more important for the state of Florida. Recent data from the Florida Medical Examiner shows residents are dying at a rate of at least 7 per day as a result of prescription drug abuse...

Sep 02, 2010 01:00AM

Surgery To Repair Torn Shoulder Muscles In The Elderly Can Reduce Pain And Improve Function

Repairing torn shoulder muscles in elderly patients is often discouraged because of fears of complications. But a new study conducted at Rush University Medical Center has shown that minimally invasive, or arthroscopic, surgery can significantly improve pain and function...

Sep 01, 2010 06:00AM

BEMA Buprenorphine Phase 2 Study Results Selected For Presentation At Pain Week 2010

BioDelivery Sciences International, Inc. (Nasdaq:BDSI) announced today that its abstract showing the results of a Phase 2 clinical study of BEMA Buprenorphine in the treatment of pain has been selected for oral presentation at Pain Week 2010, a national conference educating frontline clinicians who are faced with treating patients with pain...

Sep 01, 2010 05:00AM

After Needle Accidents, Hospitals Face Legal Dilemma If They Test Incapacitated Patients

Anaesthetists are calling for greater clarity on the legal implications of testing incapacitated patients for blood-borne viruses, after a survey found that this is often done following staff needlestick injuries, in possible breach of UK legislation...

Sep 01, 2010 02:00AM

QRxPharma To Sponsor Symposium At 13th World Congress On Pain Meeting

QRxPharma (ASX: QRX and OTCQX: QRXPY) announced it will sponsor a symposium at the 13th World Congress of Pain on 31 August, 2010 at Palais des congres de Montreal. The symposium, titled "Dual Opioid Therapy: Changing the Paradigm" will focus on preclinical and clinical data for MoxDuo®IR, an immediate-release Dual Opioid product for moderate to severe acute pain...

Sep 01, 2010 02:00AM

Glenmark Announces The Discovery Of A Novel Chemical Entity 'GRC 17536', A TRPA1 Receptor Antagonist, A Potential First-in-Class Molecule Globally

Glenmark Pharmaceuticals announced the discovery of a Novel Chemical Entity(NCE) 'GRC 17536'. The new NCE program is targeting TRPA1 receptor antagonists for pain and respiratory disorders...

Sep 01, 2010 02:00AM

MonoSol Rx Announces Reckitt Benckiser FDA Approval Of Suboxone® Sublingual Film For Treatment Of Opioid Dependence

MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, Reckitt Benckiser Pharmaceuticals Inc., a wholly-owned subsidiary of Reckitt Benckiser Group plc (LSE: RB), has received approval from the U.S...

Sep 01, 2010 01:00AM

"Pill Mill" Bill Requires State Certification By Sept. 1

Texans seeking pain relief soon can take comfort from a new state law requiring pain management clinics to be certified by the Texas Medical Board (TMB) by Sept. 1. Texas physicians hope the new law will put "pill mills," storefronts disguised as pain medicine clinics, out of commission...

Sep 06, 2010 03:00PM

The global diversion of pharmaceutical drugs. Opiate treatment and the diversion of pharmaceutical opiates: a clinician's perspective

Source: Addiction Area: Evidence > Medicines Management > References Aim: To provide a clinician's perspective on the problem of diversion of prescribed pharmaceuticals. Methods: The paper provides a personal account of working in a treatment context where diversion from opioid substitution treatment (OST) became a political issue potentially compromising the continued delivery of OST.  It summarises evidence on the impact of diversion, and measures to contain it, from the United Kingdom 1986-2006, Australia 1996-2008 and the United States and France from the mid-1990s. Results: Opioid diversion to the black market occurs in proportion to the amount of opioids prescribed to be taken without supervision, and in inverse proportion to the availability of heroin.  Diversion for ...

Sep 05, 2010 09:05PM

Early palliative care lengthens survival for lung cancer patients

A new study finds they achieved better pain symptom management and were less depressed and anxious than people receiving standard care. (Source: American Medical News - PROFESSION)

Sep 05, 2010 03:00PM

Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain

Conclusions: These results suggest that combining NMDAR antagonist ketamine with an astrocytic inhibitor or cytotoxin, which is suitable for clinical use once synthesized, might be a potential strategy for clinical management of neuropathic pain. (Source: Molecular Pain)

Sep 05, 2010 03:00PM

The practice of continuous palliative sedation in elderly patients: a nationwide explorative study among Dutch nursing home physicians

Source: Journal of the American Geriatrics Society Area: Evidence > Medicines Management > References Objectives: To study the practice of continuous palliative sedation (CPS) by Dutch nursing home physicians in 2007. Design: A structured retrospective questionnaire. Setting: Nationwide nursing home physician study in the Netherlands. Participants: 1254 nursing home physicians received a questionnaire concerning their last case of CPS in 2007; 54% (n = 675) responded. Measurements: Characteristics of CPS and requests for euthanasia were measured. Results: 316 patients were described.  The majority had cancer or dementia.  The most-reported refractory symptoms were pain (52%), anxiety (44%), exhaustion (44%), dyspnoea (40%), delirium (24%), loss of dignity (18...

Sep 03, 2010 11:00PM

Marijuana better than pharmaceuticals at treating chronic pain, improving mood

(NaturalNews) Experts from different persuasions often argue about the alleged benefits of using marijuana for pain relief, but a new study out of McGill University Health Centre (MUHC) and McGill University (MU) has conclusively found that cannabis, the genus name for marijuana, is better than pharmaceutical drugs at relieving chronic neurological pain, and without all the harmful side effects.Appearing in the latest issue of the Canadian Medical Association Journal, the study reveals that tetrahydrocannabinol (THC), the active ingredient in marijuana that gives it psychoactive and analgesic properties, is linked to relieving chronic pain, improving mood and inducing better sleep in those with severe neurological pain. Patients who took a single inhalation of marijuana smoke three times a...

Sep 03, 2010 10:02PM

Summit: Pain relief sought as human right

MONTREAL, Sept. 4 (UPI) -- Eighty percent of people with chronic pain do not get relief and there are those who want pain treatment to be a human right, an Australian pain expert says. Chronic pain - Pain management - Health - Conditions and Diseases - Human rights (Source: Health News - UPI.com)

Sep 02, 2010 06:56AM

ERCP experience in patients with choledochoduodenostomy: diagnostic findings and therapeutic management

Conclusions  We have reported one of the largest groups of patients with CD in the literature and showed that ERCP is a very important diagnostic and therapeutic tool for the management of biliary problems after CD. Content Type Journal ArticleDOI 10.1007/s00464-010-1313-6Authors Bilge Tunc Demirel, Department of Gastroenterology, Turkiye Yuksek Ihtisas Hospital, Kizilay sok. No: 2, Sihhiye, Ankara, TurkeyMurat Kekilli, Department of Gastroenterology, Turkiye Yuksek Ihtisas Hospital, Kizilay sok. No: 2, Sihhiye, Ankara, TurkeyIbrahim Koral Onal, Department of Gastroenterology, Turkiye Yuksek Ihtisas Hospital, Kizilay sok. No: 2, Sihhiye, Ankara, TurkeyErkan Parlak, Department of Gastroenterology, Turkiye Yuksek Ihtisas Hospital, Kizilay sok. No: 2, Sihhiye, Ankara, Tu...

Sep 02, 2010 02:00AM

Putting on a brave face: Sugar not effective at relieving pain for babies

Sucrose, a type of sugar, given to newborn babies as a routine form of pain relief does not work, according to a study funded by the MRC. This could lead to important future changes in the management of pain relief for newborn babies. (Source: Medical Research Council Research News)

Sep 01, 2010 10:31PM

Long proximal femoral nails versus short proximal femoral nails for the management of proximal femoral fractures: a retrospective study of 124 patients

The objective of this study is to compare the results of the Long Proximal Femoral Nail versus Short Proximal Femoral Nail in the management of proximal femoral fractures. This is a retrospective study of 124 patients with proximal femoral fracture in adult age group treated with Long Proximal Femoral Nail and Short Proximal Femoral Nail and followed up for minimum period of 6 months at last follow-up. Pain, walking ability, complications, revision surgery, and Harris Hip Score are seen in final follow-up. The conclusion of the study is that complications of Short Proximal Femoral Nail like thigh pain and femoral shaft fracture distal to the nail tips are mostly prevented by the use of Long Proximal Femoral Nail. Content Type Journal ArticleDOI 10.1007/s00590-010-0683-8Autho...

Sep 01, 2010 10:31PM

Bone mineral density, body mass index, postmenopausal period and outcomes of low back pain treatment in Korean postmenopausal women

In conclusion, age, postmenopausal length and BMI correlate with BMD in Korean women suffering from LBP. Larger studies investigating the associations between menopause, BMD, BMI and LBP seem desirable. Moreover, evidence-based therapeutic approaches should be explored for BMD and LBP management. Content Type Journal ArticleDOI 10.1007/s00586-010-1559-7Authors Jongbae J. Park, Department of Physical Medicine and Rehabilitation, School of Medicine, University of North Carolina, Campus Box #7200, Chapel Hill, NC 27599-7200, USAJoonshik Shin, Jaseng Hospital, Seoul, South KoreaYousuk Youn, Jaseng Hospital, Seoul, South KoreaCatherine Champagne, Department of Physical Medicine and Rehabilitation, School of Medicine, University of North Carolina, Campus Box #7200, Chapel Hill, NC 27599...

Sep 01, 2010 08:57PM

Ketoprofen pharmacokinetics, efficacy, and tolerability in pediatric patients.

In conclusion, ketoprofen is effective and well tolerated in children for the control of post-surgical pain and for the control of pain and fever in inflammatory conditions. PMID: 20799760 [PubMed - in process] (Source: Paediatric Drugs)

Sep 01, 2010 07:13PM

Spoonful of Sugar Debunked as Baby Painkiller (CME/CE)

(MedPage Today) -- Sugar given to blunt pain in newborns undergoing invasive procedures may only mask signs of distress, researchers found. (Source: MedPage Today Pain Management)

Sep 01, 2010 12:00AM

"Pill Mill" Bill Requires State Certification By Sept. 1

Texans seeking pain relief soon can take comfort from a new state law requiring pain management clinics to be certified by the Texas Medical Board (TMB) by Sept. 1. Texas physicians hope the new law will put "pill mills," storefronts disguised as pain medicine clinics, out of commission. These storefronts skirt the patient-physician relationship by providing powerful narcotic prescriptions without requiring a patient exam, explains Texas Medicine magazine, the official publication of the Texas Medical Association (TMA)... (Source: Health News from Medical News Today)

Aug 31, 2010 11:29PM

PAINWeek 2010 Debuts Advanced Information Management for Attendees and...

Aventine Co., producers of PAINWeek®, the nation’s premier professional conference devoted to pain education, announces that this year’s event will be enhanced by the latest technology in...(PRWeb August 30, 2010)Read the full story at http://www.prweb.com/releases/2010/08/prweb4436044.htm (Source: PRWeb: Medical Pharmaceuticals)

Aug 31, 2010 04:00PM

Local Wound Care for Malignant and Palliative Wounds

PURPOSE: To enhance the clinician's competence in providing local wound care for malignant and palliative wounds. TARGET AUDIENCE: This continuing education activity is intended for physicians and nurses with an interest in skin and wound care. OBJECTIVES: After participating in this educational activity, the participant should be better able to: 1. Apply patient prognosis to realistic outcomes, patient education, and pain management strategies. 2. Demonstrate ability to assess wounds and select appropriate dressings. 3. Analyze patient scenarios for use of various non-dressing wound treatment modalities. (C) 2010 Lippincott Williams & Wilkins, Inc. (Source: Advances in Skin and Wound Care)

Aug 31, 2010 03:00PM

Buprenorphine 7-Day Patch Okayed for Pain

A transdermal formulation of buprenorphine was recently approved by the Food and Drug Administration for the management of moderate to severe chronic pain in patients who require a continuous, round-the-clock opioid analgesic for an extended period of time. (Source: Clinical Neurology News)

Aug 31, 2010 03:00PM

Sickle Cell Disease: An Opportunity for Palliative Care Across the Life Span

Sickle cell disease is a chronic illness that affects patients physically and emotionally and can do so at an early age. An ecological model of palliative care that involves improved communication among the health care team, patients, and their families can be beneficial. Open and honest communication regarding advance care planning, disease management, relief of pain and other symptoms, and bereavement and grief are all important for the patient, family, and health care team. Given the multiple acute and chronic complications of sickle cell disease, an approach to care that is holistic and comprehensive may help to improve a patient's biologic function and the perceived health, functional status, and quality of life of the patient and family. (Source: Nursing Clinics of North America)

Aug 31, 2010 03:00PM

Intramedullary spinal cord cavernous malformations.

Authors: Gross BA, Du R, Popp AJ, Day AL Although originally the subject of rare case reports, intramedullary spinal cord cavernous malformations (CMs) have recently surfaced in an increasing number of case series and natural history reports in the literature. The authors reviewed 27 publications with 352 patients to consolidate modern epidemiological, natural history, and clinical and surgical data to facilitate decision making when managing these challenging vascular malformations. The mean age at presentation was 42 years without a sex predilection. Thirty-eight percent of the cases were cervical, 57% thoracic, 4% lumbar, and 1% unspecified location. Nine percent of the patients had a family history of CNS CMs. Twenty-seven percent of the patients had an associated cranial CM. On pr...

Aug 31, 2010 03:00PM

Clinical presentation and surgical management of intramedullary spinal cord cavernous malformations.

Conclusions The authors demonstrated the safety, efficacy, and durability of their surgical approach for resection of spinal intramedullary CM. Proper examination, preoperative imaging, and prompt surgical intervention were necessary for a satisfactory outcome. PMID: 20809753 [PubMed - in process] (Source: Neurosurgical Focus)

Aug 31, 2010 03:00PM

Propofol

Therapeutic Reviews aim to provide essential independent information for health professionals about drugs used in palliative and hospice care. The content is also available on www.palliativedrugs.com and will feature in future editions of the Hospice and Palliative Care Formulary USA and its British and Canadian counterparts. The series editors welcome feedback on the articles (hq@palliativedrugs.com). (Source: Journal of Pain and Symptom Management)